Robert Iannone, EVP, Global Head of R&D & CMO: Jazz Pharmaceuticals JAZZ Sell · Filed 25/11/19

Trade details

Type: Insider sale
Amount: $1,204,573.34
Shares · price: 7,159 sh · $168.26 a share
Held after: 72,628 sh
Stock: Jazz Pharmaceuticals JAZZ
Person: Robert IannoneEVP, Global Head of R&D & CMO
Trade date: 25/11/17
Filed: 25/11/19
Days to filing: 2 days

Sold 9.0% of holdings

Share of holding sold: 9.0%

Jazz Pharmaceuticals trades, last 26 weeks

What else happened in Jazz Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 25/10/18~25/12/17

Robert Iannone's recent trades

Robert IannoneEVP, Global Head of R&D & CMO
Planned sale10b5-1 planJazz Pharmaceuticals
Planned sale10b5-1 plan
Jazz Pharmaceuticals
JAZZ
$19.2M
76,921 sh
$19.2M
Filed 08/27
Traded 08/27
Robert IannoneEVP, Global Head of R&D & CMO
Planned sale10b5-1 planJazz Pharmaceuticals
Planned sale10b5-1 plan
Jazz Pharmaceuticals
JAZZ
$1.2M
7,159 sh
$1.2M
Filed 25/11/17
Traded 25/11/17
Robert IannoneEVP, Global Head of R&D & CMO
SellJazz Pharmaceuticals
Sell
Jazz Pharmaceuticals
JAZZ
$332.6K
2,403 sh
$332.6K
Filed 25/03/12
Traded 25/03/10
Robert IannoneEVP, Global Head of Research a
Planned saleJazz Pharmaceuticals
Planned sale
Jazz Pharmaceuticals
JAZZ
$256.2K
1,767 sh
$256.2K
Filed 25/03/10
Traded 25/03/10
Robert IannoneEVP, Global Head of R&D & CMO
Sell10b5-1 planJazz Pharmaceuticals
Sell10b5-1 plan
Jazz Pharmaceuticals
JAZZ
$764.6K
5,532 sh
$764.6K
Filed 25/03/07
Traded 25/03/07